{
  "ptid_time": "033_S_0922_2008-04-09",
  "img_path": "/data/qiuhui/data/adni/images/033_S_0922/2008-04-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 38,689 mm³, 28.9% above the reference mean. With a Z-score of 0.69 (75.4th percentile), this represents normal volume ; hippocampal volume measures 6,016 mm³, 25.1% below the reference mean. With a Z-score of -2.50 (0.6th percentile), this represents significant atrophy; whole brain volume measures 999,295 mm³, 11.9% below the reference mean. With a Z-score of -1.69 (4.6th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,683 mm³, 37.1% below the reference mean. With a Z-score of -2.57 (0.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 17,157 mm³, 13.8% below the reference mean. With a Z-score of -1.15 (12.5th percentile), this represents mild atrophy; middle temporal gyrus volume measures 21,653 mm³, 3.4% below the reference mean. With a Z-score of -0.28 (39.0th percentile), this represents normal volume . ",
  "text_data": "Age is 69.6 years. Gender is Male. Education: 12 years. MMSE: 25.0. Laboratory findings: Vitamin B12: 1301.00 (profound elevated); Total Bilirubin: 1.50 (profound elevated); Triglycerides (GPO): 241.00 (significant elevated); Direct Bilirubin: 0.30 (significant elevated); ALT (SGPT): 34.00 (significant elevated). APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus and entorhinal cortex (both below the 1st percentile), which are key regions affected in Alzheimer's disease (AD). Moderate whole-brain atrophy and mild fusiform gyrus atrophy further support neurodegeneration. The MMSE score of 25 is borderline but aligns with early cognitive impairment. APOE4 positivity increases AD risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to underlying Alzheimer's pathology).  \n\n**Confidence:** **High** (due to clear structural atrophy in AD-vulnerable regions, borderline MMSE, and APOE4 carrier status).  \n\n*Note: Progression to dementia is likely if hippocampal/entorhinal atrophy worsens and cognitive scores decline further.*",
  "timestamp": "2025-07-26T05:24:15.656338"
}